Filing Flows

Filing Flows › Boston Scientific (BSX) › Recalls, complaints & regulation

Boston Scientific (BSX): recalls, EPA violations, clinical trials and Federal Register

Boston Scientific (BSX) beyond its filings: 95 recalls in the last 12 months (409 in five years, 117 Class I); 1 EPA-regulated facility in violation, $11K in penalties over five years; 1 Federal Register document in a year; 71 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
BOSTON SCIENTIFIC CORP.Coventry, RIViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Boston Scientific's latest quarter

Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.

Questions

Has Boston Scientific had any recalls?

409 recalls on file over five years from the FDA, CPSC and NHTSA; 95 in the last 12 months.

Has Boston Scientific been fined by the EPA?

The 60 EPA-regulated facilities on file under its name drew $11K in penalties over five years; 1 is in violation now.

How many clinical trials does Boston Scientific have?

71 active studies on ClinicalTrials.gov, 2 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.